This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Yazici Y et al. (2005) Long term safety of methotrexate in routine clinical care: discontinuation is unusual and rarely the result of laboratory abnormalities. Ann Rheum Dis 64: 207–211
Lindberg J et al. (2006) Effect of infliximab on mRNA expression profiles in synovial tissue of rheumatoid arthritis patients. Arthritis Res Ther 8: R179
Acknowledgements
The synopsis was written by Helen Jaques, Editorial Assistant, Nature Clinical Practice.
Author information
Authors and Affiliations
Ethics declarations
Competing interests
Nancy Olsen is an equity holder of Arthrochip LLC, and she provides research support to Bristol-Myers Squibb and Genentech.
Rights and permissions
About this article
Cite this article
Olsen, N. Anti-TNF switching: effect on outcomes in patients with RA. Nat Rev Rheumatol 3, 430–431 (2007). https://doi.org/10.1038/ncprheum0535
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncprheum0535